RecruitingNot ApplicableNCT06273631

Effect of Different Carbohydrate Intake Patterns on Glycemic Control in Patients With Type 1 Diabetes


Sponsor

Yang Tao

Enrollment

80 participants

Start Date

Aug 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This multicenter, randomized, controlled, open-label clinical trial aims to evaluate the effects of different carbohydrate intake patterns on glycemic control in adults with type 1 diabetes. Participants will first complete a 2-week run-in period and will then be randomly assigned in a 1:1 ratio to one of two dietary groups. Both diets provide similar proportions of total energy from carbohydrates, protein, and fat, but differ in the sources of staple carbohydrates. In the moderate carbohydrate diet group, most staple foods are refined grains, whereas in the diverse carbohydrate diet group, approximately half of the staple foods are whole grains and legumes. 80 participants will follow the assigned dietary intervention for 2 weeks, followed by a 12-week follow-up period. The primary outcome is time in range (TIR), defined as the percentage of time that glucose levels are within the target range, measured using continuous glucose monitoring. Other measures of glycemic control, glycemic variability, insulin requirements, body measurements, metabolic indicators, and safety will also be evaluated. Exploratory analyses will assess potential changes in gut microbiota, immune function, and metabolomic profiles.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at how changing the timing and pattern of carbohydrate (starchy and sugary food) intake throughout the day affects blood sugar levels in people with type 1 diabetes. The goal is to find dietary patterns that lead to better glucose control. **You may be eligible if...** - You have been diagnosed with type 1 diabetes - You are between 18 and 70 years old - Your HbA1c (a measure of average blood sugar over 3 months) is 11% or below - Your BMI is between 18 and 25 - You have been on a stable insulin treatment plan for at least 2 months **You may NOT be eligible if...** - You are in the early "honeymoon" phase after diagnosis when your pancreas may still produce some insulin - You are pregnant or planning to become pregnant - You follow a vegetarian diet or are currently trying to lose weight Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERdiverse carbohydrate diet

Carbohydrate, protein, and fat provide 45-55%, 15-20%, and 25-35% of total dietary energy, respectively. Of the staple carbohydrate sources, 45-50% are derived from refined grains and 45-50% from whole grains and legumes. Total daily energy intake is divided among three meals, with breakfast providing 25-30% of total energy, lunch 30-40%, and dinner 30-35%.

OTHERmoderate carbohydrate diet

Carbohydrate, protein, and fat provide 45-55%, 15-20%, and 25-35% of total dietary energy, respectively. Of the staple carbohydrate sources, 90-95% are derived from refined grains. Total daily energy intake is divided among three meals, with breakfast providing 25-30% of total energy, lunch 30-40%, and dinner 30-35%.


Locations(1)

First Affiliated Hospital, Nanjing Medical University

Nanjing, Jiangsu, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06273631


Related Trials